Despite its recognition as the most prevalent HIV associated cancer, s
peculation still abounds regarding the pathogenesis of AIDS-related Ka
posi's sarcoma (AIDS-KS). However, it has been established that both c
ytokines, e.g. IL-6, and HIV-associated products, e.g., Tat, are integ
ral in AIDS-KS cellular proliferation. Further, both experimental and
clinical evidence is accumulating to link reactive oxygen intermediate
s (ROI) with both cytokine induction (primarily via nuclear factor-kap
pa B [NF-kappa B] dependent routes) as well as the subsequent cytokine
, tumor necrosis factor a (TNF alpha) stimulation of HIV replication.
Features of AIDS-KS patients, such as retention of phagocytes, presenc
e of sustained immunostimulation, and a frequent history of KS lesions
arising at traumatized sites, make oxidant stress a viable clinical f
actor in AIDS-KS development. Time course nucleotide profile analyses
show that AIDS-KS cells have an inherent, statistically significant, b
iochemical deficit, even prior to oxidant stress, due to 1) a more gly
colytic bioenergetic profile, resulting in lower levels of high energy
phosphates (impairing capacity for glutathione [GSH] synthesis and DN
A repair); 2) lower levels of NADPH (compromising the activities of GS
SC reductase and peroxidase function of catalase); and 3) reduced leve
ls of GSH (impeding both GSH peroxidase and GSH-S-transferases). Follo
wing exposure to physiologically relevant levels of H2O2, only the hum
an microvascular endothelial cells (a putative AIDS-KS progenitor cell
) responded with bioenergetic adaptations that reflected co-ordination
of energy generating and cytoprotective pathways, e.g., retention of
the cellular energy charge, increased NAD(+), and an accentuation of t
he ATP, NADPH, and total adenine nucleotide differences relative to AI
DS-KS cells. Also, some of the AIDS-KS strains retained intracellular
GSSG subsequent to oxidant challenge, inviting the formation of delete
rious protein mixed disulfides. While the results of our study address
some AIDS-KS issues, they also raise an etiological question, i.e., D
oes the inability to tolerate oxidant stress arise in conjunction with
AIDS-KS neoplastic development, or is it pre-existing in the populati
on at risk? Regardless, use of antioxidant therapy (low risk/potential
ly high benefit) in both the ''at risk'' population as well as in thos
e individuals with active disease may prove a useful preventative and/
or treatment modality. (C) 1995 Wiley-Liss, Inc.